Waltham-based Oncologie Inc. is a biotechnology company developing cancer therapies and diagnostic solutions.
Founded in 2018 and based in Waltham, US, Oncologie Inc. develops cancer treatment technologies and sells its treatment and diagnostic solutions on a subscription basis, serving clients in North America and Europe. In June 2019 it raised USD 80.00 mn in Series B funding led by Nan Fung Life Sciences and Pivotal BioVenture Partners, with Korea Investment Partners and Panacea Venture joining as new investors. It plans to expand into Europe and Asia by 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in